Patents Assigned to National Cancer Center
-
Publication number: 20230348587Abstract: An objective of the present invention is to provide an anti-TSPAN8/anti-CD3 bispecific antibody and an anti-TSPAN8 antibody usable in treatment or prevention in human. A human monoclonal antibody producing mouse was immunized with a peritoneal disseminated cancer cell isolated from a patient, to obtain an antibody 16B11 and an antibody 16B12 that selectively bind to a peritoneal disseminated cancer cell. These antibodies were anti-TSPAN8 antibodies that bind to the region from amino acid positions 126 to 155 of TSPAN8 and exhibited strong binding activity to TSPAN8 expressed in the peritoneal disseminated cancer cell. Further, an anti-TSPAN8(16B11)-anti-CD3 bispecific antibody produced based on the sequence of 16B11 exhibited a cytotoxic activity against the TSPAN8-expressing cancer cell in vitro, exerted an anti-tumor action on TSPAN8-expressing cancer cell-bearing mice in vivo, and extended the lifetime of peritoneal dissemination model mice.Type: ApplicationFiled: November 15, 2021Publication date: November 2, 2023Applicants: Astellas Pharma Inc., National Cancer CenterInventors: Yoshiyuki TENDA, Masatoshi YURI, Daisuke YAMAJUKU, Takeshi TSUTSUMI, Yuko KUSUZAKI, Hiroki SASAKI, Fumiko CHIWAKI, Masayuki KOMATSU
-
Publication number: 20230337893Abstract: Provided are an information processing device, a display method, and a program that allow to easily grasp during examination that a lesion is captured how long before from now which is detected by detection processing for an image captured by an endoscope. An information processing device (1) includes: an image acquisition unit (2) configured to sequentially acquire a current image captured by an endoscope; a lesion detection unit (3) configured to sequentially perform detection processing of a lesion site on the images sequentially acquired by the image acquisition unit (2); and a display control unit (4) configured to display, on a display device, a degree of lapse of time up to a current time from a capturing time of the image in which the lesion site is detected by the lesion detection unit (3).Type: ApplicationFiled: March 31, 2020Publication date: October 26, 2023Applicants: NEC CORPORATION, NATIONAL CANCER CENTERInventors: Ikuma TAKAHASHI, Tatsu KIMURA, Kimiyasu TAKOH, Kenichi KAMIJO, Shota OHTSUKA, Motoyasu OKUTSU, Masayoshi YAMADA, Ryuji HAMAMOTO, Yutaka SAITO
-
Patent number: 11786710Abstract: The present invention provides a skull implant-type automatic fluid drain device comprising: a body having a first port to be connected to a catheter, a second port provided opposite the first port, and a flow passage connecting the first port and the second port; a separation member for separating the flow passage into first and second sub-channels; a first valve fixed to the separation member and provided to allow the movement of a fluid that moves from the first port to the second port in the first sub-channel; and a second valve fixed to the separation member and provided to allow the movement of a fluid that moves from the second port to the first port in the second sub-channel, wherein each of the first valve and the second valve has an inflow end portion that is open and a discharge end portion provided in a closed state such that the same is selectively opened at an allowed opening pressure or higher; each of the first valve and the second valve is configured such that the inner flow sectional area deType: GrantFiled: April 24, 2018Date of Patent: October 17, 2023Assignees: National Cancer Center, Eulji University Industry Academy Cooperation FoundationInventors: Heon Yoo, Kwang Gi Kim, Young Tae Kim, Seung Hoon Lee
-
Patent number: 11788150Abstract: This invention provides a kit or a device for the detection of pancreatic cancer, comprising a nucleic acid(s) capable of specifically binding to a miRNA(s) in a sample from a subject, and a method for detecting pancreatic cancer, comprising measuring the miRNA(s) in vitro.Type: GrantFiled: December 7, 2020Date of Patent: October 17, 2023Assignees: Toray Industries, Inc., National Cancer CenterInventors: Junpei Kawauchi, Hitoshi Nobumasa, Satoko Kozono, Satoshi Kondou, Hiroko Sudo, Atsushi Ochiai, Motohiro Kojima
-
Patent number: 11761046Abstract: The present invention provides a kit or device for the detection of biliary tract cancer, and a method for detecting biliary tract cancer. The present invention relates to a kit or device for the detection of biliary tract cancer, comprising a nucleic acid capable of specifically binding to miRNA in a sample of a subject, and a method for detecting biliary tract cancer, comprising measuring the miRNA in vitro.Type: GrantFiled: September 8, 2022Date of Patent: September 19, 2023Assignees: TORAY INDUSTRIES, INC., NATIONAL CANCER CENTERInventors: Junpei Kawauchi, Hitoshi Nobumasa, Satoko Kozono, Satoshi Kondou, Hiroko Sudo, Atsushi Ochiai, Motohiro Kojima
-
Publication number: 20230288582Abstract: The disclosure relates to a device for detecting therapeutic radiation based on an optical disk with solar cells. The radiation detecting device may include at least one optical disk formed of a water-equivalent material, disposed perpendicular to a first direction in which the radiation is incident, and converting the radiation into visible light; a solar cell disposed on one side of the at least one optical disk, converting the visible light into an electrical signal; and a processing module for collecting and processing the electrical signal outputted from the solar cell.Type: ApplicationFiled: March 10, 2023Publication date: September 14, 2023Applicants: NATIONAL CANCER CENTER, SEOUL NATIONAL UNIVERSITY HOSPITALInventors: Dongho SHIN, Tae Hyun KIM, Tae-Ho KIM, Haksoo KIM, Dong-Seok SHIN, Se Byeong LEE, Youngkyung LIM, Jonghwi JEONG, Jaeman SON
-
Publication number: 20230277361Abstract: This organ protecting member (1) is used when an opening portion (36a) is formed in an abdominal wall (30) and an intestinal tract (32) is exposed to a body surface (33) from the opening portion (36a) to temporarily construct an artificial anus (34). The organ protecting member (1) includes a movement restricting part (support string (12)) configured to restrict movement of a portion of the lifted intestinal tract (32) on which the artificial anus (34) is constructed toward an abdominal cavity (35); and a cover (11) disposed between the intestinal tract (32) and an inner wall surface (36b) of the opening portion (36a) of the abdominal wall (30).Type: ApplicationFiled: July 7, 2021Publication date: September 7, 2023Applicants: National Cancer Center, SUMITOMO BAKELITE CO., LTD.Inventors: Masaaki ITO, Hiro HASEGAWA, Zenetsu SUZUKI, Akira KAWAMATA
-
Patent number: 11733250Abstract: The purpose of the present invention is to provide a simple and highly accurate method for detecting pancreatic exocrine dysfunction with minimal invasiveness to a subject. The method comprising in vitro measurement of two APOA2 protein variants, mutants thereof and/or fragments thereof in a body fluid sample derived from the subject and detection of the presence or absence of pancreatic exocrine dysfunction on the basis of the measured amounts, and a detection kit for pancreatic exocrine dysfunction including antibodies that can specifically bind to said proteins are provided.Type: GrantFiled: September 28, 2021Date of Patent: August 22, 2023Assignees: TORAY INDUSTRIES, INC., NATIONAL CANCER CENTERInventors: Michimoto Kobayashi, Mitsuaki Sanada, Yoshiyuki Sasajima, Giman Jung, Tesshi Yamada, Kazufumi Honda
-
Patent number: 11732307Abstract: An embodiment according to the present invention provides a kit or device for detection of bladder cancer, and a method for detecting bladder cancer. An embodiment according to the present invention relates to: a kit or device for detection of bladder cancer, including a nucleic acid(s) capable of specifically binding to an miRNA(s) or a complementary strand(s) thereof in a sample from a subject; and a method for detecting bladder cancer, including measuring the miRNA(s) in vitro.Type: GrantFiled: April 25, 2019Date of Patent: August 22, 2023Assignees: TORAY INDUSTRIES, INC., NATIONAL CANCER CENTERInventors: Makiko Yoshimoto, Hiroko Sudo, Satoko Kozono, Junpei Kawauchi, Takahiro Ochiya, Hiroyuki Fujimoto, Wataru Usuba, Juntaro Matsuzaki
-
Publication number: 20230255947Abstract: A pharmaceutical composition tor preventing treating cancer including a 3-ketoacyl CoA thiolase (ACAA) inhibitor and a carat in acylcarnitine carrier (CAC) inhibitor represented by Formula below: where R1 to R4 are each independently H, C1-6 alkyl substituted or unsubstituted with one or more halogen, or alkoxy substituted or unsubstituted with one or more halogen, and where the halogen is selected from F, Cl, Br, and I.Type: ApplicationFiled: July 1, 2021Publication date: August 17, 2023Applicant: NATIONAL CANCER CENTERInventor: Sooyoul KIM
-
Publication number: 20230251281Abstract: It is intended to provide a kit or a device for the detection of lung cancer and a method for detecting lung cancer. The present invention provides a kit or a device for the detection of lung cancer, comprising a nucleic acid capable of specifically binding to a miRNA in a sample from a subject, and a method for detecting lung cancer, comprising measuring the miRNA in vitro.Type: ApplicationFiled: October 31, 2022Publication date: August 10, 2023Applicants: TORAY INDUSTRIES, INC., NATIONAL CANCER CENTERInventors: Hiroko SUDO, Hitoshi NOBUMASA, Satoko KOZONO, Satoshi KONDOU, Junpei KAWAUCHI, Atsushi OCHIAI, Motohiro KOJIMA
-
Patent number: 11718663Abstract: An object of the present invention is to provide: an anti-GPC3 antibody that recognizes an epitope different from that for existing antibodies (e.g., GC33 and GC199) and can specifically bind, even in the form of single chain antibody, to GPC3 localized on a cell membrane; CAR comprising the anti-GPC3 single chain antibody; an immunocompetent cell expressing the CAR; a gene of the anti-GPC3 antibody or a gene of the CAR; a vector comprising the anti-GPC3 antibody gene or the CAR gene; a host cell in which the vector has been introduced; a method for specifically detecting GPC3; and a kit for specifically detecting GPC3. An antibody comprising particular heavy chain CDR1 to CDR3 and particular light chain CDR1 to CDR3 defined in claim 1, and specifically binding to a human-derived GPC3 polypeptide specifically binds to GPC3 localized on a cell membrane. CAR-immunocompetent cells prepared on the basis of CAR comprising such single chain antibody are useful for cancer immunotherapy.Type: GrantFiled: January 10, 2018Date of Patent: August 8, 2023Assignees: Yamaguchi University, National Cancer Center, Noile-Immune Biotech, Inc.Inventors: Koji Tamada, Yukimi Sakoda, Tetsuya Nakatsura, Keigo Saito
-
Patent number: 11717556Abstract: The present invention relates to a stemness-suppressing composition comprising an OCT4 function-inhibiting peptide and, more particularly, to a composition comprising a peptide as an effective ingredient for suppressing the stemness of various stem cells such as general stem cells, cancer stem cells, and the like, wherein the peptide inhibits the function of OCT4 by inducing the phosphorylation of OCT4. OCT4 function-inhibiting peptides of the present invention are expected to find applications in various fields through the suppressive activity thereof against stemness of stem cells.Type: GrantFiled: March 5, 2019Date of Patent: August 8, 2023Assignee: NATIONAL CANCER CENTERInventors: Hyonchol Jang, Byung Il Lee, Hong-Duk Youn, Bomin Song
-
Publication number: 20230212687Abstract: This invention provides a kit or device for detection of prostate cancer and a method for detecting prostate cancer. This invention provides a kit or device for detection of prostate cancer comprising a nucleic acid capable of specifically binding to an miRNA in a sample from a subject or a complementary strand thereof and a method for detecting prostate cancer comprising measuring the miRNA in vitro.Type: ApplicationFiled: November 17, 2022Publication date: July 6, 2023Applicants: TORAY INDUSTRIES, INC., NATIONAL CANCER CENTERInventors: Makiko YOSHIMOTO, Hiroko SUDO, Atsuko MIYANO, Satoko KOZONO, Takahiro OCHIYA, Hiroyuki FUJIMOTO, Fumihiko URABE, Juntaro MATSUZAKI
-
Publication number: 20230213523Abstract: The present invention relates to a method for providing information for cancer diagnosis or prognosis prediction by measuring the expression level of TIM-3 in CD11b+ cells. In addition, the present invention relates to a composition for cancer diagnosis or prognosis prediction comprising an agent for measuring the expression level of TIM-3 in CD11b+ cells or uses thereof. Since glial TIM-3 responds positively and uniquely to brain tumors and has specific intracellular and intercellular immune modulatory roles that may differ from TIM-3 in brain tumor microenvironment T cells, it can be effectively used in a composition or a method for providing information for cancer diagnosis or prognosis prediction.Type: ApplicationFiled: February 25, 2021Publication date: July 6, 2023Applicant: NATIONAL CANCER CENTERInventor: Eun Jung PARK
-
Publication number: 20230206447Abstract: A processor encodes a target image to derive at least one first feature amount indicating an image feature for an abnormality of a region of interest included in the target image. In addition, the processor encodes the target image to derive at least one second feature amount indicating an image feature for an image in a case in which the region of interest included in the target image is a normal region.Type: ApplicationFiled: March 2, 2023Publication date: June 29, 2023Applicants: NATIONAL CANCER CENTER, FUJIFILM CorporationInventors: Kazuma KOBAYASHI, Mototaka MIYAKE, Ryuji HAMAMOTO, Jun MASUMOTO
-
Publication number: 20230193402Abstract: This application provides a kit or a device for detection of lung cancer, comprising a nucleic acid(s) for detecting a miRNA(s) in a sample from a subject, and a method for detecting lung cancer, comprising measuring the miRNA(s) in vitro.Type: ApplicationFiled: March 10, 2023Publication date: June 22, 2023Applicants: TORAY INDUSTRIES, INC., NATIONAL CANCER CENTERInventors: Yuho KIDA, Satoko KOZONO, Hiroko SUDO, Satoshi KONDOU, Junpei KAWAUCHI, Takahiro OCHIYA, Shun-ichi WATANABE
-
Publication number: 20230180995Abstract: A medical system includes an endoscope that captures an image including an object, a moving device that includes a robot arm and that moves the endoscope in a body, and a controller that controls the moving device on the basis of the position of the object. The controller is configured to control the moving device in a first control mode in which the endoscope is caused to follow the object at a first speed and a second control mode in which the endoscope is caused to follow the object at a second speed lower than the first speed. The controller controls the moving device in the first control mode when the object is located outside a predetermined three-dimensional region set in a field of view of the endoscope. The controller controls the moving device in the second control mode when the object is located in the predetermined three-dimensional region.Type: ApplicationFiled: February 3, 2023Publication date: June 15, 2023Applicants: OLYMPUS CORPORATION, National Cancer CenterInventors: Hiroyuki TAKAYAMA, Ryota SASAI, Masaru YANAGIHARA, Chiharu MIZUTANI, Hiro HASEGAWA, Daichi KITAGUCHI, Nobuyoshi TAKESHITA, Shigehiro KOJIMA, Yuki FURUSAWA, Yumi KINEBUCHI, Masaaki ITO
-
Publication number: 20230180998Abstract: An endoscope system includes an endoscope, a moving device that moves the endoscope, a storage unit, and a processor. The storage unit stores first position information and first rotation angle information, which defines a rotation angle of an endoscope image of a first region, on the first region in a subject and second position information and second rotation angle information, which defines a rotation angle of an endoscope image of a second region, on the second region in the subject. The processor calculates third rotation angle information on a third region in the subject based on the first and second position information, the first and second rotation angle information, and third position information on the third region. If the third region includes the current imaging region, the processor rotates the endoscope image based on the third rotation angle information and outputs the rotated endoscope image to the display device.Type: ApplicationFiled: February 3, 2023Publication date: June 15, 2023Applicants: OLYMPUS CORPORATION, National Cancer CenterInventors: Chiharu MIZUTANI, Masaru YANAGIHARA, Hiroto OGIMOTO, Hiro HASEGAWA, Daichi KITAGUCHI, Nobuyoshi TAKESHITA, Shigehiro KOJIMA, Yuki FURUSAWA, Yumi KINEBUCHI, Masaaki ITO
-
Publication number: 20230180996Abstract: A controller controls an image that is captured by an image sensor of an endoscope and is displayed on the display screen of a display device. The controller includes a processor. The processor acquires a first image that is an image captured by the image sensor, detects a first angle of a surgical instrument, and generates a second image rotated with respect to the first image on the basis of the first angle and a predetermined target angle. The first angle is an angle formed by the surgical instrument in the first image with respect to a predetermined reference line that is set with respect to a plane of the first image. A second angle formed by the surgical instrument in the second image with respect to the predetermined reference line is equal to the predetermined target angle.Type: ApplicationFiled: February 3, 2023Publication date: June 15, 2023Applicants: OLYMPUS CORPORATION, National Cancer CenterInventors: Mingxuan DAI, Ryota SASAI, Hiro HASEGAWA, Daichi KITAGUCHI, Nobuyoshi TAKESHITA, Shigehiro KOJIMA, Yuki FURUSAWA, Yumi KINEBUCHI, Masaaki ITO